View in EDS HTML Full Text PDF Full Text

Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease.

Saved in:
Bibliographic Details
Title: Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease.
Authors: Rider, David1 (AUTHOR) d.rider@silence-therapeutics.com, Chivers, Simon2 (AUTHOR), Aretz, Julia1 (AUTHOR), Eisermann, Mona1 (AUTHOR), Löffler, Kathrin1 (AUTHOR), Hauptmann, Judith1 (AUTHOR), Morrison, Eliot1 (AUTHOR), Campion, Giles3 (AUTHOR)
Source: Toxicological Sciences. Oct2022, Vol. 189 Issue 2, p237-249. 13p.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:10966080
DOI:10.1093/toxsci/kfac067